{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T05:12:46Z","timestamp":1648962766473},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T00:00:00Z","timestamp":1370390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00134-013-2962-4","type":"journal-article","created":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T15:12:09Z","timestamp":1370358729000},"page":"1507-1508","source":"Crossref","is-referenced-by-count":0,"title":["Harm associated with 6\u00a0% tetrastarch 130\u00a0kDa [hydroxyethyl starch (HES) 130\/0.4 and 130\/0.42] is robust to sensitivity analysis by excluding Dolecek et\u00a0al."],"prefix":"10.1007","volume":"39","author":[{"given":"Amit","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umeer","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Brett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,5]]},"reference":[{"key":"2962_CR1","doi-asserted-by":"crossref","unstructured":"Kranke P, Roewer N, Muellenbach RM (2013) \u201cColloid twice daily\u201d is not fluid resuscitation! Inappropriate inclusion of clinical trials in meta-analyses may distract from gaps in evidence. Intensive Care Med. doi: 10.1007\/s00134-013-2954-4","DOI":"10.1007\/s00134-013-2954-4"},{"key":"2962_CR2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00134-013-2863-6","volume":"39","author":"A Patel","year":"2013","unstructured":"Patel A, Waheed U, Brett S (2013) Randomised trials of 6% tetrastarch (hydroxyethyl starch 130\/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis. Intensive Care Med 39:811\u2013822","journal-title":"Intensive Care Med"},{"key":"2962_CR3","first-page":"1622","volume":"56","author":"M Dolecek","year":"2009","unstructured":"Dolecek M, Svoboda P, Kantorova I, Scheer P, Sas I, Bibrova J, Radvanova J, Radvan M (2009) Therapeutic influence of 20% albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial. Hepatogastroenterology 56:1622\u20131628","journal-title":"Hepatogastroenterology"},{"key":"2962_CR4","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jama.2013.430","volume":"309","author":"R Zarychanski","year":"2013","unstructured":"Zarychanski R, Abou-Setta AM, Turgeon AF, Houston BL, McIntyre L, Marshall JC, Fergusson DA (2013) Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA 309:678\u2013688","journal-title":"JAMA"},{"key":"2962_CR5","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00134-013-2840-0","volume":"39","author":"DJ Gattas","year":"2013","unstructured":"Gattas DJ, Dan A, Myburgh J, Billot L, Lo S, Finfer S (2013) Fluid resuscitation with 6% hydroxyethyl starch (130\/0.4 and 130\/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med 39:558\u2013568","journal-title":"Intensive Care Med"},{"key":"2962_CR6","doi-asserted-by":"crossref","first-page":"f839","DOI":"10.1136\/bmj.f839","volume":"346","author":"N Haase","year":"2013","unstructured":"Haase N, Perner A, Hennings LI, Siegemund M, Lauridsen B, Wetterslev M, Wetterslev J (2013) Hydroxyethyl starch 130\/0.38\u20130.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 346:f839","journal-title":"BMJ"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-013-2962-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00134-013-2962-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-013-2962-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T12:55:56Z","timestamp":1558616156000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00134-013-2962-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,5]]},"references-count":6,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["2962"],"URL":"https:\/\/doi.org\/10.1007\/s00134-013-2962-4","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,5]]}}}